IN-VIVO GENE-THERAPY OF HUMAN LUNG-CANCER USING WILD-TYPE P53 DELIVERED BY RETROVIRUS

被引:23
作者
CARBONE, DP
MINNA, JD
机构
关键词
D O I
10.1093/jnci/86.19.1437
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1437 / 1438
页数:2
相关论文
共 12 条
[1]   P53-DEPENDENT APOPTOSIS IN THE ABSENCE OF TRANSCRIPTIONAL ACTIVATION OF P53-TARGET GENES [J].
CAELLES, C ;
HELMBERG, A ;
KARIN, M .
NATURE, 1994, 370 (6486) :220-223
[2]  
CARBONE DP, 1992, ADV INTERNAL MED, V37, P153
[3]  
CHEN JY, 1993, ONCOGENE, V8, P2159
[4]  
CHIBA I, 1990, ONCOGENE, V5, P1603
[5]  
DAMICO D, 1992, ONCOGENE, V7, P339
[6]  
FREEMAN SM, 1993, CANCER RES, V53, P5274
[7]  
FUJIWARA T, 1993, CANCER RES, V53, P4129
[8]   THERAPEUTIC EFFECT OF A RETROVIRAL WILD-TYPE P53 EXPRESSION VECTOR IN AN ORTHOTOPIC LUNG-CANCER MODEL [J].
FUJIWARA, T ;
CAI, DW ;
GEORGES, RN ;
MUKHOPADHYAY, T ;
GRIMM, EA ;
ROTH, JA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (19) :1458-1462
[9]   A MAMMALIAN-CELL CYCLE CHECKPOINT PATHWAY UTILIZING P53 AND GADD45 IS DEFECTIVE IN ATAXIA-TELANGIECTASIA [J].
KASTAN, MB ;
ZHAN, QM ;
ELDEIRY, WS ;
CARRIER, F ;
JACKS, T ;
WALSH, WV ;
PLUNKETT, BS ;
VOGELSTEIN, B ;
FORNACE, AJ .
CELL, 1992, 71 (04) :587-597
[10]  
Minna JD, 1989, CANCER PRINCIPLES PR, P591